"Research Faculty - IM Medical Oncology (Open Rank/Track Faculty)"

Position Overview

Tenure faculty (regardless of rank) - persons with the titles of professor, associate professor, assistant professor and instructor who serve on appointments totaling 50% or more service to the university and who are eligible for tenure or who have obtained tenure. Duties and responsibilities are assigned in accordance with the workload guidelines laid out in the pattern of administration of each faculty members tenure initiation unit (TIU) and, as appropriate, regional campus; obligations will include research, service and/or teaching or clinical practice. These faculty will have earned doctorate or other terminal degree in the relevant field of study or possession of equivalent experience.

Assistant Professor
Department of Internal Medicine, Division of Medical Oncology
College of Medicine

Visa and immigration sponsorship may be available for qualified candidates.

Education and Experience Requirements

Applicants must hold advanced degrees such as MD, DVM, PharmD, PhD, or MD/PhD. A postdoctoral fellowship in immunology, immuno-oncology, hematology, cancer genomics and/or pathobiology is required. Extensive experience leading or working with shared resource laboratories from one of these Technology Hubs is strongly preferred. Proven ability to write scientific reports and publish in scientific, peer-reviewed journals preferred; understanding of key components of grant writing and obtaining funding in support of research required; experience with administration of funded research required. Requires successful completion of a background check. Selected candidate may be requested to complete a pre-employment physical including a drug screen.

Ohio State provides access to a depth and breadth of opportunities and resources. Starting your first day, Ohio State offers you a comprehensive benefits package.

How to Apply

To be considered, please submit your application electronically via Workday. Application materials must include cover letter and Curriculum Vita. All inquiries and nominations should be directed in confidence to: Anna Godwin, Research Faculty Recruitment, Anna.Godwin@osumc.edu

Required
Cover letter
Curriculum Vita (CV)

Department Information

The Ohio State University Comprehensive Cancer Center Arthur G. James Cancer Hospital and Richard J. Solove Research Institute expanded in December 2014 to become the 3rd largest cancer hospital in the U.S. The extraordinary success of this new 398-bed state-of-the-art hospital has resulted in remarkable clinical growth and robust research portfolio. The Ohio State University is currently seeking faculty at the Assistant Professor, Associate Professor and Professor rank for a variety of roles in the areas of basic and translational research.

Features include:

• NCI-designated Comprehensive Cancer Center since 1976
• One of only 11 freestanding cancer hospitals in the U.S.
• Magnet(r) designation
• One of only four cancer centers funded by the NCI to conduct Phase I and II cancer clinical trials
• Founding member of the National Comprehensive Cancer Network (NCCN)
• Founding member of the Oncology Research Information Exchange Network (ORIEN)
• Robust clinical trials program with active translational therapeutics that include a clinical research unit, Phase 1 U01 grant and N01 Phase II contract
• Consistently ranked as one of Americas Best Cancer Hospitals by U.S. News & World Report
• Financially-secure program with strong philanthropic and community support

The PIIO is a comprehensive bench-to-bedside research initiative focused on harnessing the bodys immune system to fight cancer at all levels (https://cancer.osu.edu/piio). Launched in July 2019 as part of a $102 Million pledge from Pelotonia (pelotonia.org), the PIIO represents Ohio State's commitment to grow the exciting area of immuno-oncology. Led by founding director and renowned immunologist Zihai Li, MD, PhD, the PIIO builds upon a rich portfolio of active investigator-initiated IO clinical trials being conducted at the OSUCCC James.

Research in the PIIO centers on Systems IO (a systems-wide strategy to study the anti-cancer immune response holistically to discover the next IO breakthroughs and create effective cancer immunotherapies) and Translational IO (where we turn discoveries into new or improved cancer treatments and broaden the indications and patient populations that can be treated with cellular therapy). Our Immune Monitoring and Discovery Platform (IMDP) supports each center, providing comprehensive cell-based and molecule-based immunoassay services to support basic, translational, and clinical IO studies. The PIIOs Immuno-Oncology Informatics Group (IOIG) provides data analytics for flow and mass cytometry, bulk and single-cell RNA-Seq, spatial transcriptomics and imaging, neoantigen discovery, and more.